University Hospital of Zurich-ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2022

  1. Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021

    Transplant Infectious Disease, Vol. 24, Núm. 6

2021

  1. Infectious complications and graft outcome following treatment of acute antibodymediated rejection after kidney transplantation: A nationwide cohort study

    PLoS ONE, Vol. 16, Núm. 4 April

  2. Invasive Aspergillosis Due to Aspergillus Section Usti: A Multicenter Retrospective Study

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 72, Núm. 8, pp. 1379-1385

  3. Propensity score and desirability of outcome ranking analysis of ertapenem for treatment of nonsevere bacteremic urinary tract infections due to extended-spectrum-beta-lactamase-producing enterobacterales in kidney transplant recipients

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 11

  4. Trimethoprim/sulfamethoxazole for nocardiosis in solid organ transplant recipients: Real-life data from a multicentre retrospective study

    Transplant Infectious Disease, Vol. 23, Núm. 4

2018

  1. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Intracellular signaling pathways: tyrosine kinase and mTOR inhibitors)

    Clinical Microbiology and Infection, Vol. 24, pp. S53-S70

2015

  1. Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey

    Clinical Microbiology and Infection, Vol. 21, Núm. 6, pp. 604.e1-604.e9